Competitive Clinical Research Grant
Lilly's Competitive Clinical Research Grant funds independent investigator-initiated studies in targeted therapeutic areas to advance science and patient outcomes through industry-researcher collaboration.
Funder: Eli Lilly and Company
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Support may include study drug and/or financial funding; award size and duration vary by RFP and project scope.
Summary: Funds externally initiated clinical research in targeted therapeutic areas, with proposals selected through a competitive RFP and review process.
Description
Lilly's Competitive Clinical Research Grant program supports independent, investigator-initiated studies that address specific research questions in targeted therapeutic areas. Each cycle, Eli Lilly issues public Requests for Proposals (RFPs) focusing on particular indications or compounds. Proposals are rigorously reviewed by Lilly's global medical and scientific committees, sometimes with input from external experts. Selected projects are managed and sponsored by the grantee, with Lilly providing study drug and/or financial support as specified in the RFP. The program aims to advance scientific understanding and improve patient outcomes by fostering collaboration between industry and the research community.
